Pancreatic Cancer Research

ResearcherVita-Salute San Raffaele UniversityActive in the last 2 years

Kofi W. Oppong

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-7381-7412; OpenAlex author ID A5037724712, A5103868661. Sources: OpenAlex.

Their work

Papers
8
Trials
0
Grants
0
Labs led
0
Collaborators
47
Papers, trials and grants by year

2017: 1 paper · 2018: 1 paper · 2019: 1 paper · 2020: none · 2021: 2 papers · 2022: 2 papers · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 8

  1. Risk-stratified surveillance for individuals in the UK at high risk of developing pancreatic cancer: Outcomes from the European Registry of Hereditary Pancreat… Co-author DOI 10.1016/j.ejca.2026.116592↗
  2. Rate of pancreatic cancer following a negative endoscopic ultrasound and associated factors. Co-author DOI 10.1055/a-1784-1661↗
  3. Correction: Rate of pancreatic cancer following a negative endoscopic ultrasound and associated factors. Co-author DOI 10.1055/a-1868-8796↗
  4. Morphological and p40 immunohistochemical analysis of squamous differentiation in endoscopic ultrasound guided fine needle biopsies of pancreatic ductal adenoc… Co-author DOI 10.1038/s41598-021-00652-5↗
  5. Impact of pancreatic enzyme replacement therapy on short- and long-term outcomes in advanced pancreatic cancer: meta-analysis of randomized controlled trials. Co-author DOI 10.1080/17474124.2021.1884544↗
  6. Changes in tumor vascularity depicted by contrast-enhanced EUS as a predictor of prognosis and treatment efficacy in patients with unresectable pancreatic canc… Co-author DOI 10.4103/eus.eus_16_19↗
  7. Diagnosis and management of pancreatic cancer in adults: A summary of guidelines from the UK National Institute for Health and Care Excellence. Co-author DOI 10.1016/j.pan.2018.09.012↗
  8. Pancreatic ductal adenocarcinoma epidemiology and risk assessment: Could we prevent? Possibility for an early diagnosis Co-author DOI 10.4103/eus.eus_60_17↗

Closest collaborators

The 25 strongest of 47 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. John Samuel Leeds · 4 shared papers, 2021–2022 · strength 0.56
  2. Nigel John Trudgill · 2 shared papers, 2022 · strength 0.30
  3. Dominic Stephen King · 2 shared papers, 2022 · strength 0.30
  4. Stephen P. Pereira · 2 shared papers, 2019–2026 · strength 0.29
  5. Annabelle Boughey · 1 shared paper, 2026 · strength 0.22
  6. Paula Ghaneh · 1 shared paper, 2026 · strength 0.22
  7. Mark Taylor · 1 shared paper, 2026 · strength 0.22
  8. Tejinderjit Athwal · 1 shared paper, 2026 · strength 0.22
  9. Andrew Malvern Smith · 1 shared paper, 2026 · strength 0.22
  10. Guruprasad Padur Aithal · 1 shared paper, 2026 · strength 0.22
  11. Phillip J. Hopley · 1 shared paper, 2026 · strength 0.22
  12. Zaed Z. R. Hamady · 1 shared paper, 2026 · strength 0.22
  13. William Greenhalf · 1 shared paper, 2026 · strength 0.22
  14. Christopher Michael Halloran · 1 shared paper, 2026 · strength 0.22
  15. Eithne Costello · 1 shared paper, 2026 · strength 0.22
  16. Noor L. H. Bekkali · 1 shared paper, 2017 · strength 0.15
  17. Benjamin P. T. Loveday · 1 shared paper, 2021 · strength 0.13
  18. Bathiya Ratnayake · 1 shared paper, 2021 · strength 0.13
  19. Khaled Ammar · 1 shared paper, 2021 · strength 0.13
  20. Sanjay Pandanaboyana · 1 shared paper, 2021 · strength 0.13
  21. Manu K. Nayar · 1 shared paper, 2021 · strength 0.13
  22. Beate Haugk · 1 shared paper, 2021 · strength 0.13
  23. JulioIglesias Garcia · 1 shared paper, 2019 · strength 0.07
  24. Michael Hocke · 1 shared paper, 2019 · strength 0.07
  25. Mariana Jinga · 1 shared paper, 2019 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.